CJC-1295 (no DAC)

CJC-1295 (No DAC) (Research Peptide)

For Research Use Only – Not for Human Consumption, Diagnostic, or Therapeutic Use. CJC-1295 (No DAC) is supplied strictly for laboratory and scientific research applications, such as in vitro and in vivo studies on growth hormone-releasing hormone (GHRH) signaling, pulsatile GH release, IGF-1 modulation, body composition, and metabolic regulation. All information below is for educational and research reference only.

What Is CJC-1295 (No DAC)?

CJC-1295 (No DAC) is a synthetic tetrapeptide analogue of growth hormone-releasing hormone (GHRH 1-29). The "No DAC" version lacks the Drug Affinity Complex (DAC) modification, resulting in a shorter half-life that more closely mimics the natural pulsatile release of growth hormone.

Typically supplied as a lyophilized powder (acetate salt form) for reconstitution in research settings.

Key Research Findings and Potential Areas of Study

Preclinical and early research models show:

• Increased pulsatile GH secretion and subsequent IGF-1 levels

• Support for lean body mass, fat metabolism, and recovery processes

• Improved sleep quality and recovery markers in certain animal models

• Synergistic effects when combined with other GH secretagogues (e.g., Ipamorelin)

It is frequently used in studies exploring optimized GHRH analogues for metabolic and anabolic research.

Why Researchers Choose CJC-1295 (No DAC)

CJC-1295 (No DAC) is a preferred short-acting GHRH analogue for researchers who want to study more natural, pulsatile GH release patterns rather than sustained elevation. It is an excellent tool for metabolic, body composition, and recovery studies, especially when paired with other secretagogues.

Questions about specifications, COA, or research applications? Contact our support team.

All products are for research purposes only. Not intended for human use.